Find more information about Teva in your location, or contact a local representative on our local sites

We found your location:

United States

Continue

North America

Canada
United States

International Markets

Argentina
Australia
Belarus
Brazil
Chile
China
Hong Kong SAR
India
Indonesia
Israel
Japan
Kazakhstan
Kyrgyzstan
Mexico
New Zealand
Peru
Russia
Singapore
South Africa
South Korea
Thailand
Turkey
Ukraine
Uruguay

Europe

Austria
Belgium
Bosnia and Herzegovina
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Macedonia
Malta
Netherlands
Norway
Poland
Portugal
Romania
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
United Kingdom

North America

Toggle North America

Canada
United States

International Markets

Toggle International Markets

Argentina
Australia
Belarus
Brazil
Chile
China
Hong Kong SAR
India
Indonesia
Israel
Japan
Kazakhstan
Kyrgyzstan
Mexico
New Zealand
Peru
Russia
Singapore
South Africa
South Korea
Thailand
Turkey
Ukraine
Uruguay

Europe

Toggle Europe

Austria
Belgium
Bosnia and Herzegovina
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Macedonia
Malta
Netherlands
Norway
Poland
Portugal
Romania
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
United Kingdom

Investors
News & Media

Our Company Toggle Our Company
As a global leader in generic medicines with a strong innovative portfolio, we are all in for better health.
Product Focus Toggle Product Focus
Quality, accessibility, and innovation, without compromise
Patients & Caregivers Toggle Patients & Caregivers
Our Impact Toggle Our Impact
Acting responsibly and ethically in all we do helps ensure our sustainability—allowing Teva to provide treatments to those who need them for years to come.
Your Career Toggle Your Career
Working at Teva is not just a job, it’s so much more than that. Here, you get to spend each day helping millions of people around the world enjoy healthier lives. At the same time, you’ll be joining a dedicated team, united by the strong sense that we’re building something greater than ourselves.
Contact Us

Home
News and Media
Latest News

Latest News

Year

January 13, 2025

Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel

January 10, 2025

Teva and Samsung Bioepis Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States

December 23, 2024

Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference

December 20, 2024

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025

December 17, 2024

Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease

December 11, 2024

Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients

At Teva, we strive to deliver quality medicines to patients around the world with integrity and ethical business practices. What we do is important, but how we do it is just as important. Learn more:

Teva Code of Conduct

Supplier Code of Conduct

Environmental, Social and Governance at Teva

All Corporate Governance & Policy Documents

Contact Us
Terms of Use
Social Media Guidelines
Teva api
Medis

Sitemap
Data Privacy
Pharmacovigilance Privacy Notice
Accessibility Statement

You are about to leave the Teva Pharmaceuticals global website

The website you are about to access may be governed by different regional policies, regulations or advertising codes. Please be sure to read the privacy policy and terms of use of the websites that you visit.

Teva Pharmaceuticals is not responsible for the accuracy or compliance with laws of information on any third party websites.

Do you wish to proceed?